Gates Package — page 490

From: "Billet, Courtney (NIH/NIAID) [E]" [@niaid.nih.gov> To: "Mascola, John (NIH/VRC) [E]" HE 221 ih. gov> Ce: "Daucher, Marybeth )) [E]" HR 2 viaid nih gov>, "Chan, Alan (NIH/VRC) [F]" mail nih.gov>, "Stover, Kathy (NIH/NIAID) [E]" nih.gov>, "Koup, Richard (NIH/VRC) [E]" [@mail nih. gov>, "Graham, [H/VRC) [E]" )mail.nih.gov>, "Kelley, Ken )) [C]" Bame' \nih.gov>, "Mittelman, Abraham (NIH/VRC) [C]" ail_nih.gov>, "Kwong, Peter (NIH/VRC) [E]" BEE email nin. gov, Folkers, Greg (NIH/NIAID) [E]" niaid.nih.gov>, "Vance, Meaghan (NIH/NIAID) [C]" nih.gov> Subject: RE: JOHN: June NIH/BMGF meeting Date: Fri, 12 May 2017 10:36:21 -0400 Importance: Normal Just came from morning meeting. ASF agrees with your approach and would indeed like to do the usual format used for VIP visits, where he presents some slides and then turns it to you. Greg will take the lead on ASF's slides. I'll ask Rob Eiss to keep me in the loop on the Gates cameraperson's needs. If there's anything that requires any sort of set-up, my office will coordinate that with Marybeth, the way we would with a media film crew. From: Billet, Courtney (NIH/NIAID) [E] Sent: Thursday, May 11, 2017 9:47 PM To: Mascola, John (NIH/VRC) [E] Cc: Daucher, Marybeth (NIH/NIAID) [E] Stover, Kathy (NIH/NIAID) [E] mail.nih.gov> niaid.nih.gov>; Chan, Alan (NIH/VRC) [E] I mail.nih.gov>; nih.gov>; Koup, Richard (NIH/VRC) [E] gov>; Graham, Barney (NIH/VRC) [E] mail.nih.gov>; Kelley, Ken (NIH/NIAID) [C] Mittelman, Abraham (NIH/VRC) [C] mail.nih.gov>; Kwong, Peter (NIH/VRC) [E] Subject: Re: JOHN: June NIH/BMGF meeting nih.gov>; mail.nih.gov> Sounds good to me. I'll mention to Tony and see if he wants to preface the overview. Pretty sure he will want to - you two have done that drill before. I'll be back in touch. Thanks! On May 11, 2017, at 8:37 PM, Mascola, John (NIH/VRC) [E] HR oil nih. gov> wrote: Hi Courtney, Thanks for the update. We will hold the 1-2pm timeframe on June gn. and Marybeth can be POC for coordinating logistics. I don't think Bill knows much about VRC; i.e. our portfolio of diseases, technologies, capabilities, pilot plan etc, so I think it would be useful for me to give a 15 min overview. Tony can decide if he wants to preface that. While tours are great -- at the end of the day, a lab is a lab, so I favor Given that a hour often ends up being 50 min, I'd propose 15 min overview and 5 min questions and 30 min tour. For tour -- given BMGF request to focus on structure-based vaccine design, that should be one key element Tour